APA (7th ed.) Citation

Deqing, W. [Comment] Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older pa tients with RAS wild-type metastatic colorectal cancer: An analysis of the randomised trial FIRE-3. Editorial Office of Journal of Colorectal & Anal Surgery.

Chicago Style (17th ed.) Citation

Deqing, Wu. [Comment] Efficacy of FOLFIRI Plus Cetuximab Vs FOLFIRI Plus Bevacizumab in 1st-line Treatment of Older Pa Tients with RAS Wild-type Metastatic Colorectal Cancer: An Analysis of the Randomised Trial FIRE-3. Editorial Office of Journal of Colorectal & Anal Surgery.

MLA (9th ed.) Citation

Deqing, Wu. [Comment] Efficacy of FOLFIRI Plus Cetuximab Vs FOLFIRI Plus Bevacizumab in 1st-line Treatment of Older Pa Tients with RAS Wild-type Metastatic Colorectal Cancer: An Analysis of the Randomised Trial FIRE-3. Editorial Office of Journal of Colorectal & Anal Surgery.